
欧洲神经毒素市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型(Botox、Dysport、Xenomin 等)、应用(治疗和美容)和最终用户(医院、专科诊所、皮肤科诊所等) )
No. of Pages: 119 | Report Code: BMIRE00028618 | Category: Life Sciences
No. of Pages: 119 | Report Code: BMIRE00028618 | Category: Life Sciences
结构变化影响由于细胞功能随着年龄的增长而下降,皮肤、肌肉、韧带、脂肪和骨骼在人的脸上变得很明显。许多人通常不积极地看待衰老这一不可避免的生理过程,这反过来又促使他们沉迷于美容年轻化手术,以在视觉上保持年轻。肉毒杆菌毒素 (BOTA) 是整容手术中最常用的神经毒素。治疗上述病例的 BOTA 选择涉及含有 500 个欧洲单位的 Abobotulinum A(ABO;Dysport/Ipsen Limited,斯劳伯克郡,英国)。按照制造商推荐的2.5ml盐水溶液与500单位肉毒毒素的施用比例,进行重构。因此,涉及神经毒素的整容手术越来越受欢迎,以减少面部皱纹,同时确保安全性、有效性和效率,这正在促进神经毒素市场的发展。
欧洲神经毒素市场已细分为英国、德国、法国、意大利、西班牙、波兰、俄罗斯和欧洲其他地区。老年人口的激增、产品推出的增加、神经毒素产品分销的增加以及政府对非手术美容产品和程序的监管不断加强可能会促进市场增长。此外,美容诊所数量的增加可能为市场增长提供重要的增长机会。在英国,没有行业来规范非手术程序的标准。此外,进行肉毒杆菌或填充剂注射程序不需要法律许可。因此,这些是过去几年全国神经毒素市场增长的主要因素。然而,2013 年,英国健康教育局针对从业者未能改善公共保护并降低可能导致美容手术严重副作用的风险制定了标准和资格框架。
< p>
欧洲神经毒素市场分为产品类型、应用、最终用户和国家。< /span>
根据产品类型,欧洲神经毒素市场分为肉毒杆菌、dysport、xenomin 等。肉毒杆菌细分市场在 2023 年占据最大的市场份额。
根据应用,欧洲神经毒素市场分为治疗和美容。到2023年,治疗领域将占据更大的市场份额。
根据最终用户,市场分为医院、专科诊所、皮肤科诊所等。 2023 年,医院细分市场占据最大的市场份额。
根据国家/地区,市场分为英国、德国、法国、意大利、西班牙、波兰、俄罗斯,以及欧洲其他地区。德国在 2023 年占据市场份额。
AbbVie Inc、Evolus Inc、Hugel Inc、Ipsen SA、Meditox Inc 和 Merz Pharma GmbH & Co KGaA 是欧洲神经毒素市场的领先公司之一。
Strategic insights for Europe Neurotoxins involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 1,174.94 Million |
Market Size by 2028 | US$ 2,038.94 Million |
Global CAGR (2022 - 2028) | 11.7% |
Historical Data | 2021-2022 |
Forecast period | 2024-2028 |
Segments Covered |
By 产品类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Neurotoxins refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Neurotoxins Market is valued at US$ 1,174.94 Million in 2023, it is projected to reach US$ 2,038.94 Million by 2028.
As per our report Europe Neurotoxins Market, the market size is valued at US$ 1,174.94 Million in 2023, projecting it to reach US$ 2,038.94 Million by 2028. This translates to a CAGR of approximately 11.7% during the forecast period.
The Europe Neurotoxins Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Neurotoxins Market report:
The Europe Neurotoxins Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Neurotoxins Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Neurotoxins Market value chain can benefit from the information contained in a comprehensive market report.